Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) has received a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation. Brokerages have set a one year consensus price objective of $7.50 for the […]
